EnzBond Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$24.1K
- Investors
-
3
EnzBond General Information
Description
Developer of an automated in silico platform designed to understand the enzyme evolution process. The company's platform is capable of predicting enzyme activity with accuracy and at speeds faster than alternative methods and can be applied to any enzyme regardless of sequence, structure, or catalytic characteristics, enabling chemical industries to screen thousands of initial mutants that result in efficient predictions of the most active enzymes.
Contact Information
Website
www.enzbond.comCorporate Office
- 105 Victoria Street
- 6th Floor, Westminster
- London SW1E 6DT
- England, United Kingdom
Corporate Office
- 105 Victoria Street
- 6th Floor, Westminster
- London SW1E 6DT
- England, United Kingdom
EnzBond Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 01-Apr-2019 | $24.1K | Completed | Product Development | ||
| 3. Early Stage VC (Series A) | 05-Feb-2019 | Completed | Product Development | |||
| 2. Seed Round | 06-Dec-2016 | $437K | $437K | Completed | Product Development | |
| 1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
EnzBond Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
EnzBond Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
EnzBond Patents
EnzBond Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202316771-D0 | Enzymes for the production of complex anmine products | Pending | 01-Nov-2023 | ||
| GB-202216087-D0 | Enzymes for the production of complex amine products | Inactive | 31-Oct-2022 | ||
| GB-202210858-D0 | Method to produce novel amino acid | Inactive | 25-Jul-2022 | ||
| GB-202110503-D0 | Method to produce novel amino acid | Inactive | 21-Jul-2021 | ||
| GB-202100181-D0 | Modular production of peptides and derivatives | Inactive | 07-Jan-2021 |
EnzBond Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
EnzBond Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovate UK | Government | |||
| Oxford Science Enterprises | Venture Capital | Minority | ||
| University of Oxford | University | Minority |
EnzBond FAQs
-
When was EnzBond founded?
EnzBond was founded in 2015.
-
Where is EnzBond headquartered?
EnzBond is headquartered in London, United Kingdom.
-
What is the size of EnzBond?
EnzBond has 3 total employees.
-
What industry is EnzBond in?
EnzBond’s primary industry is Discovery Tools (Healthcare).
-
Is EnzBond a private or public company?
EnzBond is a Private company.
-
What is EnzBond’s current revenue?
The current revenue for EnzBond is .
-
How much funding has EnzBond raised over time?
EnzBond has raised $2.23M.
-
Who are EnzBond’s investors?
Innovate UK, Oxford Science Enterprises, and University of Oxford have invested in EnzBond.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
